Altered Circulating Immune Cell Distribution in Traumatic Spinal Cord Injury Patients in Relation to Clinical

Judith Fraussen1, Lien Beckers1, Charlotte C M van Laake-Geelen2,3

  • 1Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Hasselt, Belgium.

Insights

Spinal cord injury (SCI) triggers inflammation, altering immune cells. This study found memory B cells and CD74 expression are key in SCI, offering potential biomarkers for disease severity and neuroinflammation.

Area of Science:

  • Immunology
  • Neuroscience
  • Cell Biology

Background:

  • Spinal cord injury (SCI) initiates an inflammatory cascade, leading to secondary tissue damage.
  • The systemic immune response following SCI remains incompletely understood.
  • Understanding immune cell dynamics is crucial for managing SCI outcomes.

Purpose of the Study:

  • To comprehensively analyze circulating immune cell composition in traumatic SCI patients.
  • To correlate immune cell profiles with clinical parameters and disease severity.
  • To investigate the role of specific immune cell subsets and markers in SCI pathogenesis.

Main Methods:

  • High-dimensional flow cytometry was employed on peripheral blood mononuclear cells.
  • Samples were analyzed from 18 traumatic SCI patients and 18 healthy controls.
  • Immune cell subsets were quantified at (sub)acute and chronic SCI phases.

Main Results:

  • Increased total and CD4+ T cell frequencies were observed in chronic SCI (cSCI) patients.
  • Both CD4+ T cells and B cells exhibited a shift towards memory phenotypes post-SCI.
  • Significant alterations in the B cell compartment included decreased IgG+ and increased IgM+ frequencies, correlating with American Spinal Injury Association (ASIA) impairment scale (AIS) scores.
  • Increased CD74+ cells and CD74 expression were noted on B cells in SCI patients.

Conclusions:

  • Post-SCI inflammation appears to be driven by memory immune cell subsets.
  • Elevated CD74 expression on B cells suggests potential involvement of CD74-related pathways in neuroinflammation.
  • Circulating IgM+ and IgG+ B cell levels may hold prognostic value for SCI patients.